title: Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines.
abstract: CYP3A activity is induced by approximately 2-fold during the third trimester of human pregnancy. Placental growth hormone (PGH), estrogens (primarily 17β-estradiol), cortisol, and progesterone have the potential to modulate CYP3A activity. Therefore, we determined whether the elevated plasma concentrations of these hormones during pregnancy induce hepatic CYP3A expression. We incubated sandwich-cultured human hepatocytes (SCHH) from premenopausal female donors (n = 2) with the physiologic (unbound, 1× total) and the 10× total third trimester hormone plasma concentrations (individually and in combination) and determined their effect on CYP3A activity and the transcripts of CYP3A4, CYP3A5, and the respective hormone receptors (growth hormone receptor, glucocorticoid receptor, and estrogen receptor alpha). Of all the hormones, cortisol was the most potent inducer of CYP3A activity and CYP3A4, CYP3A5 mRNA expression. The combination of PGH/growth hormone and cortisol induced CYP3A activity and expression significantly more than did cortisol alone. When incubated with the unbound or total plasma concentration of all the hormones, CYP3A activity in SCHH was induced to an extent comparable to that observed in vivo during the third trimester. These hormones had only a modest effect on the mRNA expression of the hormone receptors. The pattern of induction observed in SCHH was reproduced in HepaRG cells but not in HuH7/HepG2 cells. SCHH or HepaRG cells could be used to determine the mechanistic basis of CYP3A induction during pregnancy and to predict the magnitude of induction likely to be observed during the first and second trimesters, when phenotyping studies to measure in vivo CYP3A activity are logistically difficult to perform.
authors.affiliation: Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195-7610, USA.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Papageorgiou
authors.forename: Susan
authors.initials: S
authors.lastname: Grepper
authors.forename: Jashvant D
authors.initials: JD
authors.lastname: Unadkat
mesh_terms: D051544:Cytochrome P-450 CYP3A / Q000096:biosynthesis* / Q000235:genetics; D004790:Enzyme Induction; D004958:Estradiol / Q000494:pharmacology; D004964:Estriol / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000187:drug effects / Q000378:metabolism; D005260:Female; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology*; D010926:Placental Hormones / Q000494:pharmacology; D017698:Postmenopause / Q000378:metabolism; D011247:Pregnancy; D011264:Pregnancy Trimesters / Q000378:metabolism; D017697:Premenopause / Q000378:metabolism; D061251:Primary Cell Culture; D011374:Progesterone / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000378:metabolism; D011986:Receptors, Somatotropin / Q000187:drug effects / Q000378:metabolism; D013739:Testosterone / Q000494:pharmacology
chemical_list: C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D010926:Placental Hormones; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D011986:Receptors, Somatotropin; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; C510164:CYP3A5 protein, human; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D004964:Estriol; D006854:Hydrocortisone